Skip to main content

Diabetes

  • Kerr Drug hosts North Carolina launch of Script Your Future campaign

    RALEIGH, N.C. — Kerr Drug is hosting the North Carolina launch of the National Consumer League’s “Script Your Future” medication adherence campaign, the regional retail pharmacy chain said.

  • Hypoglycemic events can disrupt work productivity for diabetics, survey finds

    COPENHAGEN, Denmark — A new survey sponsored by drug maker Novo Nordisk, which polled Type 1 and Type 2 diabetes patients in the United States, United Kingdom, Germany and France, found that about 1-in-5 respondents regularly are unable to attend a full day of work due to disruption caused by episodes of dangerously low blood sugar, also known as hypoglycemic events.

  • HbA1C test may not be useful among dialysis patients with diabetes

    WINSTON-SALEM, N.C. — The gold standard long-term glucose monitoring test for patients with diabetes proved to be of limited value in dialysis patients, according to a new study at Wake Forest Baptist Medical Center released Wednesday.

  • Diamyd Medical earns back rights to diabetes drug from J&J subsidiary

    STOCKHOLM — Swedish drug maker Diamyd Medical has regained control of its investigational drug for Type 1 diabetes following Johnson & Johnson’s termination of a development deal between the two companies.

  • MinuteClinic offers free diabetes monitoring package

    WOONSOCKET, R.I. — CVS Caremark's MinuteClinic locations are offering a free diabetes monitoring package this summer, the company announced on Friday.

    The monitoring package administered by a MinuteClinic practitioner includes hemoglobin A1C and blood glucose tests, a blood pressure check, body mass index, cholesterol test, comprehensive foot exam and microalbumin test (kidney function check). The practitioner also will conduct a review of lifestyle factors and give immediate results and recommendations.

  • Insulet acquires Neighborhood Diabetes

    BEDFORD, Mass. — A company that develops insulin-pump technology without tubing, such as the OmniPod insulin management system, has acquired a durable medical equipment distributor that specializes in direct-to-consumer sales of diabetes supplies.

  • Aristides Spanellis prohibited from buying, selling LifeScan's blood-glucose monitoring test strips

    MILPITAS, Calif. — LifeScan announced a major settlement regarding counterfeit packaged LifeScan blood-glucose monitoring test strips sold by Aristides Spanellis.

  • GDM risk can be assessed prior to pregnancy

    OAKLAND, Calif. — A woman's risk of developing a type of diabetes typically caused by pregnancy can be identified up to seven years prior to becoming pregnant, according to a new study by Kaiser Permanente.

    The study, part of Kaiser Permanente's ongoing research to understand, prevent and treat gestational diabetes mellitus, found that routinely assessing blood sugar and body weight measures can provide women with insight on their risk of developing GDM.

X
This ad will auto-close in 10 seconds